Beam Therapeutics Inc. P/S ratio

P/S ratio of BEAM for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/S ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its sales per share. It is used by investors mainly because it’s less volatile than P/E and less subject to accounting manipulation. A low P/S ratio compare to historical average or other companies in the same industry might indicate undervaluation.


Highlights and Quick Summary

Current P/S ratio of Beam Therapeutics Inc. is 98.73 (as of December 31, 2021)
  • P/S ratio for the quarter ending September 30, 2022 was 36.44 (a 3.14% increase compared to previous quarter)
  • Year-over-year quarterly P/S ratio decreased by -63.08%
  • Annual P/S ratio for 2021 was 98.73 (a -99.94% decrease from previous year)
  • Annual P/S ratio for 2020 was 158970.77 (a Infinity% increase from previous year)
Visit stockrow.com/BEAM for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/S ratio of Beam Therapeutics Inc.

Most recent P/S ratioof BEAM including historical data for past 10 years.

Interactive Chart of P/S ratio of Beam Therapeutics Inc.

Beam Therapeutics Inc. P/S ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 36.44 35.34 65.32
2021 98.73 7395.03 333628.12 200800.68 98.73
2020 158970.77 51381.73 57668.45 23043.83 158970.77
2019 0.0 0.0 0.0 0.0

Business Profile of Beam Therapeutics Inc.

Sector: Healthcare
Industry: Biotechnology